Research progress on androgen receptor in triple-negative breast carcinoma

doi:10.3969/j.issn.1007-3969.2016.05.020

Abstract

Abstract: Triple-negative breast cancers (TNBC) comprise a heterogeneous group of tumors characterized by poor survival and lack of targeted therapeutics. In recent years, androgen receptor (AR) has been demonstrated to play an important role in the genesis and development of TNBC. There has been increased interest in the role of AR in TNBC and AR-targeting has been introduced as a novel therapeutic option for TNBC. This review offers an overview of the relationship between AR expression and TNBC, and provides insights into the novel drugs in the development for targeting this signaling pathway.

Key words: Triple-negative breast cancer, Androgen receptor, Expression

LIU Xiaoli, JIANG Da, CUI Yanzhi. Research progress on androgen receptor in triple-negative breast carcinoma[J]. China Oncology, 2016, 26(5): 466-470.

[1]	WANG Qing, YU Yushuai, WANG Chenxi, JIANG Zirong, LI Jialu, TANG Shicong, SONG Chuangui. Current status and prospects of tertiary lymphoid structure heterogeneity in predicting response to neoadjuvant therapy and characterizing immune microenvironment in triple-negative breast cancer [J]. China Oncology, 2025, 35(2): 213-218.
[2]	CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong. The progress of treatment for brain metastases of triple-negative breast cancer [J]. China Oncology, 2024, 34(8): 777-784.
[3]	CHEN Junyao, ZHANG Wentao, LIU Qiao, NIE Jianyun. Clinical dilemma and systemic treatment strategy of triple-negative breast cancer in the elderly [J]. China Oncology, 2023, 33(5): 506-516.
[4]	SHAO Zhibo, YANG Benlong, WU Jiong. Progress of important clinical trials of breast cancer in China in 2022 [J]. China Oncology, 2023, 33(2): 103-109.
[5]	GUO Qing, ZHANG Jian. Advances in targeted therapy for HER2-low breast cancer [J]. China Oncology, 2023, 33(2): 181-190.
[6]	ZHANG Xiaowei, LIU Xin, LUO Zhiguo. Progress in clinical management of cancer of unknown primary based on molecular testing at 2023 ESMO [J]. China Oncology, 2023, 33(11): 989-992.
[7]	XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin. New research advances and future prospect in precision treatment of triple-negative breast cancer [J]. China Oncology, 2022, 32(8): 669-679.
[8]	GONG Chao , CHEN Kui , ZHANG Dekun , XIE Jingfeng , WU Fanghua , HUANG Yudian , XUE Yuqin , WANG Liqun . Construction of a prediction model for metastasis in gastric cancer based on the weighted gene co-expression network analysis [J]. China Oncology, 2021, 31(8): 746-753.
[9]	LIU Bin , ZHENG Pengyuan , MI Yang , REN Feifei , GAO Shuang , LIU Chuan , LI Fazhan . Expression of LRP8 in gastric cancer and its significance in tumorigenesis [J]. China Oncology, 2021, 31(4): 285-293.
[10]	HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang . Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer [J]. China Oncology, 2021, 31(3): 221-226.
[11]	CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei . Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score [J]. China Oncology, 2020, 30(7): 505-511.
[12]	JIANG Mengyi , LU Yanqiao , WANG Hongxia . Research progress and clinical significance of breast cancer heterogeneity [J]. China Oncology, 2020, 30(5): 394-400.
[13]	SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng . Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer [J]. China Oncology, 2020, 30(3): 186-191.
[14]	CAO Xiaoshan, CONG Binbin. The progress of treatment for triple-negative breast cancer in the era of precision medicine [J]. China Oncology, 2019, 29(12): 971-976.
[15]	ZHENG Xiaying, CHEN Junxia. Expression of circRNA hsa_circ_0005320 in triple-negative breast cancer and its effect on cell proliferation [J]. China Oncology, 2019, 29(11): 845-854.

Research progress on androgen receptor in triple-negative breast carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments